rs121918507
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PP2PP3_ModeratePP5_Very_Strong
The NM_000141.5(FGFR2):c.1576A>G(p.Lys526Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000141.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGFR2 | ENST00000358487.10 | c.1576A>G | p.Lys526Glu | missense_variant | Exon 12 of 18 | 1 | NM_000141.5 | ENSP00000351276.6 | ||
FGFR2 | ENST00000457416.7 | c.1579A>G | p.Lys527Glu | missense_variant | Exon 12 of 18 | 1 | ENSP00000410294.2 | |||
FGFR2 | ENST00000369056.5 | c.1579A>G | p.Lys527Glu | missense_variant | Exon 11 of 17 | 1 | ENSP00000358052.1 | |||
FGFR2 | ENST00000369058.7 | c.1579A>G | p.Lys527Glu | missense_variant | Exon 12 of 17 | 1 | ENSP00000358054.3 | |||
FGFR2 | ENST00000613048.4 | c.1309A>G | p.Lys437Glu | missense_variant | Exon 11 of 17 | 5 | ENSP00000484154.1 | |||
FGFR2 | ENST00000369061.8 | c.1240A>G | p.Lys414Glu | missense_variant | Exon 9 of 15 | 1 | ENSP00000358057.4 | |||
FGFR2 | ENST00000369059.5 | c.1234A>G | p.Lys412Glu | missense_variant | Exon 10 of 16 | 5 | ENSP00000358055.1 | |||
FGFR2 | ENST00000360144.7 | c.1312A>G | p.Lys438Glu | missense_variant | Exon 11 of 17 | 2 | ENSP00000353262.3 | |||
FGFR2 | ENST00000478859.5 | c.892A>G | p.Lys298Glu | missense_variant | Exon 11 of 17 | 1 | ENSP00000474011.1 | |||
FGFR2 | ENST00000429361.5 | c.352A>G | p.Lys118Glu | missense_variant | Exon 4 of 9 | 5 | ENSP00000404219.1 | |||
FGFR2 | ENST00000604236.5 | n.*623A>G | non_coding_transcript_exon_variant | Exon 11 of 17 | 1 | ENSP00000474109.1 | ||||
FGFR2 | ENST00000604236.5 | n.*623A>G | 3_prime_UTR_variant | Exon 11 of 17 | 1 | ENSP00000474109.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
FGFR2-related craniosynostosis Pathogenic:1
This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 526 of the FGFR2 protein (p.Lys526Glu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant FGFR2-related conditions (PMID: 15523492, 16061565; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 13295). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FGFR2 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
Crouzon syndrome Pathogenic:1
- -
Familial scaphocephaly syndrome, McGillivray type Pathogenic:1
- -
Pfeiffer syndrome Pathogenic:1
- -
not provided Pathogenic:1
Published functional studies demonstrate a damaging effect: increased activation of the FGFR2 kinase (PMID: 17803937); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 16061565, 17803937, 15523492) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at